 Connection
Ihab Kamel to Drug Therapy, Combination
This is a "connection" page, showing publications Ihab Kamel has written about Drug Therapy, Combination.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.158 |
|
|
|
-
Corona-Villalobos CP, Halappa VG, Geschwind JF, Bonekamp S, Reyes D, Cosgrove D, Pawlik TM, Kamel IR. Volumetric assessment of tumour response using functional MR imaging in patients with hepatocellular carcinoma treated with a combination of doxorubicin-eluting beads and sorafenib. Eur Radiol. 2015 Feb; 25(2):380-90.
Score: 0.091
-
Salas A, Fatola A, Krimins R, Kamel IR, Geetha D, Fine D, Monroy-Trujillo M, Rosenberg A, Arend L, Timlin H. COVID vaccine-induced lupus nephritis: Case report and review of the literature. Lupus. 2024 Feb; 33(2):176-182.
Score: 0.043
-
Cosgrove DP, Reyes DK, Pawlik TM, Feng AL, Kamel IR, Geschwind JF. Open-Label Single-Arm Phase II Trial of Sorafenib Therapy with Drug-eluting Bead Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma: Clinical Results. Radiology. 2015 Nov; 277(2):594-603.
Score: 0.024
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|